StonvexLoading…
StonvexStonvexStonvexCore line items from CNVS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Annual 2025 2025-03-31 |
|---|---|---|---|---|
Revenue | $39.76M | $23.48M | $11.12M | $78.18M |
Operating Income | $-9.77M | $-9.11M | $-3.70M | $7.92M |
Net Income | $-875.00K | $-5.54M | $-3.52M | $3.76M |
EPS (Diluted) | $-0.57 | $-0.53 | $-0.21 | $0.16 |
Total Assets | $68.57M | $61.95M | $61.53M | $72.52M |
Total Liabilities | $30.83M | $24.78M | $25.38M | $34.72M |
Cash & Equivalents | $2.46M | $2.34M | $1.99M | $13.94M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 18.22M | 17.72M | 16.99M | 17.82M |